5 Ways to Increase Weight Loss on Wegovy: UK Guide

You've been injecting Wegovy every week. You're eating less than you used to. And the scale has decided to sit still.

That gap between what you expected and what you're seeing is one of the most common things people bring to us. Usually nothing has gone wrong. The ways to increase weight loss on Wegovy that make a measurable difference are specific and fixable, and most of them start with where you are on the dose schedule.

Before you try to increase weight loss on Wegovy, check the calendar

Before changing anything, it helps to know where you are on the schedule. Wegovy isn't a medicine that works on week one and plateaus by week six. It's designed to be built up slowly.

According to the Wegovy Summary of Product Characteristics, you start at 0.25mg once weekly and step up over a 16-week period to the 2.4mg maintenance dose. That escalation exists to keep nausea and vomiting manageable, not to slow you down on purpose. If you're eight weeks in and disappointed, you're comparing yourself to results that were measured after 68 weeks.

There's a useful number buried in the STEP 2 data. After roughly 28 weeks of treatment, 74.7% of people on semaglutide 2.4mg had lost at least 5% of their starting weight. Of the quarter who hadn't, 31.9% still got there by week 68. Nearly a third of the people who looked like non-responders at six months weren't.

Patience does more work here than most people give it credit for. But patience alone isn't a plan, so here are the five things that make the biggest difference.

1. Get to a dose that's doing something

This is the single most common reason for disappointing results, and it's the easiest to check.

Wegovy comes in six weekly strengths. The escalation runs 0.25mg, 0.5mg, 1mg, 1.7mg and then 2.4mg, with four weeks at each step. If you need more, the SmPC allows an increase to 7.2mg once weekly after a minimum of four weeks on 2.4mg.

The dose gap matters more than people assume. In STEP UP, a 72-week trial of 1,005 people on 7.2mg, average weight loss was 18.7%, compared with 15.6% for the 2.4mg group and 3.9% for placebo. At the higher dose, 47.7% of people lost at least a fifth of their body weight.

Two situations are worth flagging to your prescriber. If you've been stuck on 1mg for three months because a dose increase felt daunting, you're on a dose that was designed as a stepping stone. And if you're settled on 2.4mg, tolerating it well, and your loss has flattened out for a couple of months, 7.2mg exists for exactly that conversation. Our full Wegovy dosage guide walks through each strength.

2. Put protein first at every meal

Semaglutide works partly by slowing how quickly your stomach empties and reducing how much you want to eat. In a phase 1 study, energy intake at a free-access meal was 35% lower on semaglutide 2.4mg than on placebo after 20 weeks of dosing.

That's the medicine doing its job. When total intake drops that far, though, what goes into the smaller window starts to matter enormously.

Protein is the priority. It keeps you full for longer, it's the nutrient your body needs to hold onto muscle while fat comes off, and it's the one most people quietly under-eat once their appetite fades. Eat it first, before the vegetables and the carbohydrate, while you still have room.

Practical version: a palm-sized portion of chicken, fish, eggs, tofu, tempeh, beans or Greek yoghurt at every meal you eat. If breakfast has become a coffee and half a slice of toast, that's a whole meal's worth of protein you're not getting. Our guide to high-protein, low-calorie foods has UK supermarket options that work when appetite is low.

There's evidence this matters for body composition, not just the scale. In an MRI sub-study within STEP UP, 55 participants showed a greater reduction in fat mass than in lean body mass over 72 weeks, meaning their body composition improved rather than simply shrank. Protein intake and training are what push that balance further in your favour.

3. Add two strength sessions a week

Walking more is good. It won't protect your muscle.

The NHS physical activity guidelines ask adults for at least 150 minutes of moderate intensity activity a week, or 75 minutes of vigorous activity, plus strengthening activities that work all the major muscle groups on at least two days a week. Most people on GLP-1 medication do the first part and skip the second.

Those two strength sessions are where the returns are. Muscle is metabolically expensive tissue, so keeping it means your resting energy expenditure falls less than it otherwise would as you get lighter. It also determines how you look and move at your goal weight, which is the part nobody mentions until they get there.

You don't need a gym membership. The NHS counts resistance bands, bodyweight exercises, carrying heavy shopping, yoga, pilates and heavy gardening. Two sessions of twenty minutes, hitting legs, back, chest and arms, is a reasonable floor. We've written more on maintaining muscle while on GLP-1 medications if you want a starting routine.

4. Build the deficit on purpose

Wegovy makes a calorie deficit easier to hold. It doesn't create one for you.

The NHS puts the recommended daily average at 2,000 calories for women and 2,500 for men to maintain weight, and suggests reducing intake by around 600 calories a day to lose it safely. Every major Wegovy trial ran on that principle: participants in STEP 1, 2 and 4 all followed a 500 kcal per day deficit alongside the injection.

The pattern we see most often runs like this. Appetite drops, meals get smaller, and people stop paying attention because they assume the medicine has it covered. Then the softer calories creep back: a flat white with full-fat milk, a glass of wine most evenings, the biscuit that comes with the tea. None of these feel like eating. All of them count.

You don't need to track forever. Two weeks of honest logging will tell you more than two months of guessing, and most people find one or two specific habits that account for the whole gap. If you've already done this and the numbers add up, our piece on why you might not be losing weight in a calorie deficit covers the less obvious explanations.

One thing to be careful about: eating far too little is its own problem. If Wegovy has taken your intake down to 800 calories a day, you're heading for muscle loss, fatigue and nutrient gaps rather than faster results. Tell your prescriber if that's where you've landed.

5. Look at sleep, stress and what you're drinking

These three get treated as soft advice. They're not.

Poor sleep changes appetite hormones and makes higher-calorie food far harder to resist the next day. Chronic stress does something similar, and it tends to arrive alongside the exact eating patterns you're trying to change. If you're running on five hours and a permanent knot in your stomach, no dose of semaglutide fully compensates for that.

Alcohol is the one people leave out of the conversation entirely. It's calorie-dense, it lowers the resolve that gets you through an evening without snacking, and the NHS advice on semaglutide is that it's best not to drink on it at all, because alcohol can worsen side effects like nausea and vomiting. Plenty of our patients find their tolerance drops noticeably once they're on maintenance.

Start with whichever of the three is most obviously broken. Fixing sleep first tends to make the other two easier. Our post on stress and weight gain goes further into the mechanism if that's your sticking point.

The unglamorous mechanics that keep you on treatment

Every one of the five points above assumes you're still taking the medication in six months' time. A surprising number of people aren't, and it's rarely because the drug stopped working. It's because a bad fortnight of nausea turned into a skipped dose, then a skipped month, then a restart from a lower strength.

Getting the mechanics right protects the whole plan.

Inject on the same day each week. The NHS says you can move your injection day if you need to, as long as at least three days have passed since your last dose, and the time of day doesn't matter. Pick a day that suits your week rather than one that leaves the worst of any nausea landing on a Saturday.

Rotate your sites. Wegovy goes into the fatty tissue of the thigh, tummy or upper arm, and you should change the spot each week, even within the same area. Repeatedly using one patch of skin gets sore and can make absorption less predictable. Our guide on where to inject Wegovy covers a simple rotation pattern.

If you miss a dose, the rule is straightforward: if it's been five days or less since it was due, take it as soon as you remember. If it's been longer, skip it and carry on with your usual day. Never double up.

And manage the side effects rather than enduring them. Nausea usually improves within the first few weeks at each new strength. Constipation responds to fibre, fluid and movement well before it needs anything stronger. Both are easier to fix early, and both are common reasons people stall halfway up the dose ladder and never reach the strength the trials were run on.

What the trials suggest about doing all of this together

Most articles on this topic list the same five tips and leave you to take them on faith. The Wegovy trial programme happens to contain a natural comparison.

STEP 1 gave 1,306 people semaglutide 2.4mg with general instructions on a reduced-calorie diet and increased activity. Average weight loss at 68 weeks: 14.9%.

STEP 3 gave 407 people the same 2.4mg dose, but wrapped it in intensive behavioural therapy: an initial eight-week low-calorie diet of 1,000 to 1,200 kcal a day, then 60 weeks at 1,200 to 1,800 kcal, activity building from 100 to 200 minutes a week, and regular behavioural counselling. Average weight loss at 68 weeks: 16.0%. In that trial, 53.5% of participants lost at least 15% of their body weight, against 47.9% in STEP 1.

Same medicine. Same dose. Different scaffolding around it. Both figures come from the Wegovy SmPC, and the comparison is across separate trials rather than a head-to-head, so treat the gap as directional rather than precise. But it points the same way everything above points: the injection sets the conditions, and what you build around it decides how much of the available result you actually get.

When it's the medication, not you

Sometimes the honest answer is that this particular drug isn't the right fit.

The SmPC sets a clear checkpoint: if you haven't lost at least 5% of your starting body weight after six months of treatment, a decision is needed on whether to continue, weighing up the benefits and risks for you specifically. That's a designed review point, not a failure.

Even at the highest dose, response isn't universal. In STEP UP, 90.7% of people on 7.2mg lost at least 5% of their body weight, which also means around 9% didn't.

If you've reached a proper maintenance dose, given it a fair run, and put the diet, training and sleep pieces in place, the conversation shifts to alternatives. Tirzepatide, the active ingredient in Mounjaro, targets two hormone receptors rather than one, and some people who respond modestly to semaglutide do better on it. We compare the two in Wegovy vs Mounjaro, and if you're considering the move, switching between them is something a prescriber should plan with you rather than something to improvise.

Underlying conditions matter too. Hypothyroidism, PCOS and insulin resistance all make weight loss harder, and if you've never had them ruled out, that's worth a blood test.

How much weight should you expect, and by when?

It depends on your dose, your starting weight and how long you stay on treatment. These are the trial averages, all from the Wegovy SmPC.

Averages hide a wide spread. Some people land well above these figures and some well below, and your own trajectory tells you more than any trial mean. What the numbers do establish is the timescale: these results were measured over a year and a quarter, not over a fortnight. If you're judging Wegovy at week ten, you're judging it too early. Our guide on how long GLP-1s take to start working sets out a more realistic week-by-week picture.

This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional before starting any treatment.